Literature DB >> 25133279

Intravenous thrombolysis in stroke patients receiving rivaroxaban.

D J Seiffge, C Traenka, H Gensicke, D A Tsakiris, L H Bonati, N Peters, P Lyrer, S T Engelter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 25133279     DOI： 10.1111/ene.12285

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN： 1351-5101            Impact factor:   6.089


× No keyword cloud information.
  4 in total

1.  Feasibility of rapid measurement of Rivaroxaban plasma levels in patients with acute stroke.

Authors:  David J Seiffge; Christopher Traenka; Alexandros Polymeris; Lisa Hert; Urs Fisch; Nils Peters; Gian Marco De Marchis; Raphael Guzman; Christian H Nickel; Philipp A Lyrer; Leo H Bonati; Dimitrios Tsakiris; Stefan Engelter
Journal:  J Thromb Thrombolysis       Date:  2017-01       Impact factor: 2.300

2.  Intravenous Thrombolysis in Patients with Stroke Taking Rivaroxaban Using Drug Specific Plasma Levels: Experience with a Standard Operation Procedure in Clinical Practice.

Authors:  David J Seiffge; Christopher Traenka; Alexandros A Polymeris; Sebastian Thilemann; Benjamin Wagner; Lisa Hert; Mandy D Müller; Henrik Gensicke; Nils Peters; Christian H Nickel; Christoph Stippich; Raoul Sutter; Stephan Marsch; Urs Fisch; Raphael Guzman; Gian Marco De Marchis; Philippe A Lyrer; Leo H Bonati; Dimitrios A Tsakiris; Stefan T Engelter
Journal:  J Stroke       Date:  2017-09-06       Impact factor: 6.967

3.  Thrombolysis in an acute ischemic stroke patient with rivaroxaban anticoagulation: A case report.

Authors:  Yen-Tung Chao; Chaur-Jong Hu; Lung Chan
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.889

Review 4.  Recanalisation therapies for acute ischaemic stroke in patients on direct oral anticoagulants.

Authors:  Duncan Wilson; Teddy Y Wu; David J Seiffge; Thomas Meinel; Jan Christoph Purrucker; Johannes Kaesmacher; Urs Fischer
Journal:  J Neurol Neurosurg Psychiatry       Date:  2021-02-04       Impact factor: 10.154
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.